Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Panagiota Zarmpi"'
Autor:
M. Alice Maciel Tabosa, Pauline Vitry, Panagiota Zarmpi, Annette L. Bunge, Natalie A. Belsey, Dimitrios Tsikritsis, Timothy J. Woodman, K.A. Jane White, M. Begoña Delgado-Charro, Richard H. Guy
Publikováno v:
Molecular Pharmaceutics. 20:2527-2535
Publikováno v:
Biopharmaceutics. :113-133
Publikováno v:
Fagerberg, J H, Zarmpi, P, Jabbar, H & Fotaki, N 2021, ' Affinity of Lipophilic Drugs to Mixed Lipid Aggregates in Simulated Gastrointestinal Fluids ', Journal of Pharmaceutical Sciences, vol. 110, no. 1, pp. 186-197 . https://doi.org/10.1016/j.xphs.2020.09.053
Mixed lipid aggregates, comprising of bile salts and phospholipids, present in the small intestine assist in drug solubilization and subsequent drug dissolution and absorption through the intestinal epithelium. The increased variability in their leve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9ca67a0cd726ecd4f6056ae6a46860e5
https://purehost.bath.ac.uk/ws/files/214916433/Lipophilic_drugs_and_mixed_aggregates_Dr_N_Fotaki.pdf
https://purehost.bath.ac.uk/ws/files/214916433/Lipophilic_drugs_and_mixed_aggregates_Dr_N_Fotaki.pdf
Autor:
James Mann, Elizabeth Meehan, Panagiota Zarmpi, Talia Flanagan, Nikoletta Fotaki, Jesper Østergaard
Publikováno v:
Zarmpi, P, Flanagan, T, Meehan, E, Mann, J, Østergaard, J & Fotaki, N 2020, ' Biopharmaceutical implications of excipient variability on drug dissolution from immediate release products ', European Journal of Pharmaceutics and Biopharmaceutics, vol. 154, pp. 195-209 . https://doi.org/10.1016/j.ejpb.2020.07.014
Elucidating the impact of excipient variability on oral product performance in a biopharmaceutical perspective would be beneficial and allow excipient implementation on Quality by Design (QbD) approaches. The current study investigated the impact of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53702eca7ccb5ca036f9f37b8c1341e6
https://purehost.bath.ac.uk/ws/files/210941906/Excipient_and_dissolution_Dr_N_Fotaki.pdf
https://purehost.bath.ac.uk/ws/files/210941906/Excipient_and_dissolution_Dr_N_Fotaki.pdf
Publikováno v:
The AAPS Journal
The presence of different excipient types/brands in solid oral dosage forms may affect product performance and drug bioavailability. Understanding the biopharmaceutical implications of superdisintegrant variability (changes in material properties), v
Publikováno v:
The AAPS Journal
Identification of the biopharmaceutical risks of excipients and excipient variability on oral drug performance can be beneficial for the development of robust oral drug formulations. The current study investigated the impact of Hypromellose (HPMC) pr
Publikováno v:
Zarmpi, P, Flanagan, T, Meehan, E, Mann, J & Fotaki, N 2020, ' Surface dissolution UV imaging for characterization of superdisintegrants and their impact on drug dissolution ', International Journal of Pharmaceutics, vol. 577, 119080 . https://doi.org/10.1016/j.ijpharm.2020.119080
Superdisintegrants are a key excipient used in immediate release formulations to promote fast tablet disintegration, therefore understanding the impact of superdisintegrant variability on product performance is important. The current study examined t
Publikováno v:
Baxevanis, F, Zarmpi, P, Kuiper, J & Fotaki, N 2020, ' Investigation of drug partition kinetics to fat in simulated fed state gastric conditions based on drug properties ', European Journal of Pharmaceutical Sciences, vol. 146, 105263 . https://doi.org/10.1016/j.ejps.2020.105263
The presence of fat in the gastric environment can affect the pharmacokinetic behaviour of drugs with mechanisms which have not been yet fully understood. The objective of the current study was to assess the drug partition to the lipid part of the fe
Publikováno v:
The AAPS Journal
Excipients are major components of oral solid dosage forms, and changes in their critical material attributes (excipient variability) and/or amount (excipient variation) in pharmaceutical formulations may present a challenge for product performance.
Publikováno v:
Zarmpi, P, Flanagan, T, Meehan, E, Mann, J & Fotaki, N 2017, ' Biopharmaceutical aspects and implications of excipient variability in drug product performance ', European Journal of Pharmaceutics and Biopharmaceutics, vol. 111, pp. 1-15 . https://doi.org/10.1016/j.ejpb.2016.11.004
Implementation of Quality by Design approaches in pharmaceutical industry requires a sound understanding of the parameters triggering final product variability. Excipients, although generally regarded as inert components, are of great significance in